On Monday, May 12, President Donald Trump signed an Executive Order (EO) titled, “Delivering Most-Favored-Nation Prescription Drug Pricing to Americans,” aimed at reducing prescription drug prices by implementing a...more
For private equity investors, the arrival of the 119th Congress and the new Trump administration shifts the landscape, creating uncertainty, challenge and opportunity in equal measure and highlighting the need for political...more
2/12/2025
/ Acquisition Agreements ,
Antitrust Division ,
Cryptocurrency ,
Digital Assets ,
Energy Sector ,
Foreign Investment ,
Merger Agreements ,
Private Equity ,
Public Policy ,
Regulatory Agenda ,
Sustainability ,
Trade Relations ,
Trump Administration